FDA Inspection 851899 — Similasan AG

Similasan AG — FEI 1000110034

The FDA completed an inspection of Similasan AG on September 13, 2013 in Jonen. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 13, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Jonen (Switzerland)